Jerda M Riley MD

Jerda M Riley MD, a woman-owned sole proprietorship based in Chicago, Illinois, delivers independent medical reviews of Social Security Administration disability claim case files as a prime contractor under blanket purchase agreements, with all 61 recent awards (100% of prime footprint) issued by SSA without set-aside designation.

Dr. Riley operates exclusively within a single customer relationship. The Social Security Administration accounts for 60 of 61 awards and $7.9 million of the $8.5 million combined potential value across the portfolio. Work is performed in Chicago in Region 5, covering the Midwest and Western region of SSA's disability determination footprint. The source material does not describe Dr. Riley as holding any SBA certification (8(a), HUBZone, SDVOSB, WOSB, or other), despite the woman-owned business designation; awards consistently carry no set-aside language.

Dr. Riley's capability portfolio centers on independent case review — the core service — supplemented by non-case services such as orientation and training for new medical consultants. Representative awards include a $169,884 BPA call from May 2026 requiring independent medical reviews of disability claim case files with a completion date of June 30, 2027; a $126,720 firm fixed-price call order from July 2025 for regional medical contractor services in the Midwest/West region extending through June 2026; and a $129,393 award from July 2023 for 1,450 independent case reviews in support of SSA's disability determination process. Call orders range from as low as $1,120 to as high as $169,884 across the portfolio. Dr. Riley's work is categorized under NAICS Offices of Physicians (43 awards) and Offices of Physicians, Mental Health Specialists (18 awards), with PSC coding split between Medical-Medical/Psychiatric Consultation (29 awards), Support-Administrative Court Reporting (12 awards), and Medical-Other (10 awards).

Dr. Riley sits on four blanket purchase agreements with SSA: BPA SS10631150308 (17 task orders, $59 thousand combined value), BPA 28321321AC0540033 (14 task orders, $884 thousand), BPA SS051140082 (11 task orders, $652 thousand), and BPA SS05164C021 (11 task orders, $747 thousand). Activity has been episodic rather than growth-oriented — two awards in 2022, five in 2023, three in 2024, two in 2025, and one in 2026 — with only one award ($170 thousand potential value) reaching ultimate completion within the next twenty-four months, suggesting minimal recompete exposure in the near term. Combined obligated dollars stand at $3.5 million against $8.5 million potential value, reflecting a 41% invoiced-revenue rate across the award set. Dr. Riley operates as a solo prime with no recorded subcontractor relationships.